Celanese Corp., US1510201049

Celanese Corp. stock gains after value-focused analysis highlights upside potential

Published on 09/16/2026 at 22:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Celanese Corp. stock closed at USD 44.78 on September 14, 2026 on the NYSE, about 26.6 percent below a GF Value estimate of USD 64.32. The shares then rebounded intraday to USD 45.92, leaving room to the 52-week range for value-oriented investors.

Luftaufnahme einer großen Spezialchemie-Produktionsanlage bei Sonnenuntergang in Irving Texas — Celanese Corp. Chemieanlagengelände in Irving Texas mit Destillationstürmen und Kühltürmen fotografiert US1510201049, Illustration mit AI erstellt.

Celanese Corp. stock (ISIN US1510201049) recently caught investors' attention as valuation metrics suggest notable upside versus its current market price of USD 47.22 as of September 15, 2026 on the New York Stock Exchange. According to GuruFocus on September 15, 2026, the shares recently gained 5.5 percent but still trade 26.6 percent below an estimated fair value of USD 64.32, framing the current move as a value-driven reaction rather than a fully priced rally.

Valuation signal and recent price action

As of the close on September 14, 2026, Celanese Corp. stock stood at USD 44.78 on the NYSE, representing a daily decline of 2.84 percent from the prior session, before bouncing to an after-hours quote of USD 45.92, up 2.57 percent from that close, per data reported by Yahoo Finance on September 14, 2026. The valuation analysis from GuruFocus calculates a GF Value estimate of USD 64.32, indicating that the current price of USD 47.22 on September 15, 2026 is 26.6 percent below this fair value marker and therefore potentially undervalued on that model. For investors, the quantified gap between the latest trading level and the GF Value benchmark is the core of the current narrative: Celanese shares have already advanced 5.5 percent in the latest move, yet the model still implies roughly a one-quarter upside from the present level.

Beyond the headline undervaluation, the same analysis assigns Celanese a GF Score of 65 out of 100, with a profitability sub-score of 7 out of 10 and a valuation sub-score of 4 out of 10, while financial strength and momentum are scored at 4 out of 10 and 3 out of 10 respectively, as outlined by GuruFocus. The above-average overall score and strong profitability metrics support the case that the stock's discounted valuation is not simply a reflection of fundamentally weak operations, but they also highlight that leverage and share-price momentum remain risk factors.

Fundamental profile and recent performance metrics

Celanese is described in the GF Score analysis as a chemical company with exposure to specialty materials, and the scorecard shows that growth is rated 4 out of 10, which points to a moderate expansion profile rather than high-growth dynamics according to GuruFocus. In the same framework, the valuation sub-score of 4 out of 10 is paired with the explicit GF Value estimate, reinforcing the idea that the shares trade below intrinsic value but not at a distressed level.

While the GF Score does not replace traditional quarterly figures, it synthesizes Celanese's recent revenue trends, margins and cash generation into a single composite view, with the 65 out of 100 outcome positioning the company as above average versus its peers along key financial dimensions per GuruFocus. For value-oriented investors, one practical interpretation is that Celanese offers a combination of solid profitability and reasonable growth at a price that, on this model, still reflects skepticism about future earnings and balance-sheet resilience.

The same analysis notes that Celanese stock is currently held by seven institutional investors tracked on the platform, with four increasing their positions and four trimming holdings in recent quarters, which underlines a mixed but engaged shareholder base as reported by GuruFocus. That split positioning reflects how the stock's risk-reward profile, with leverage and cyclical exposure on one side and valuation upside on the other, is being actively debated.

Risk factors and what to watch next

The GF Score framework explicitly flags Celanese's weaker momentum and financial strength scores as areas investors should monitor, with momentum rated at 3 out of 10 and financial strength at 4 out of 10, signaling that the share price trend and balance-sheet metrics could amplify volatility according to GuruFocus. In practice, that means any disappointment in upcoming quarterly earnings, cash flow or debt-reduction progress could narrow the valuation gap more through a lower GF Value estimate than through a rising share price.

For the next months, the key checkpoints for Celanese Corp. stock will be the company’s scheduled financial reports and any updates to guidance or capital-allocation plans, which typically appear on its investor-relations pages at Celanese. If revenue growth stabilizes or margins improve in the latest quarter while leverage trends better than feared, the current 26.6 percent discount to the GF Value estimate could begin to close; conversely, further signs of cyclical slowing or higher financing costs might justify the market's cautious stance and keep the GF Score anchored around its present 65 out of 100 level.

Celanese Corp. stock price and key market data

Celanese Corp. stock is listed on the New York Stock Exchange under the ticker CE, with a recent closing price of USD 44.78 on September 14, 2026 and an after-hours quote of USD 45.92 that same day in United States trading, per price data visible on exchange-linked portals. The GF Value analysis highlights a contemporaneous price of USD 47.22 on September 15, 2026 versus an estimated fair value of USD 64.32, meaning the shares traded roughly one-quarter below that fair value reference at that time. Traders also monitor Celanese's 52-week range and market capitalization to gauge where the current price sits in its yearly context and how large the company is within the chemical sector.